Clearance of intracellular pathogens, such as Leishmania (L.) major, depends on 26 an immune response with well-regulated cytokine signaling. Here we describe a 27 pathogen-mediated mechanism of evading CXCL10, a chemokine with diverse 28 antimicrobial functions, including T cell recruitment. Infection with L. major in a human 29 monocyte cell line induced robust CXCL10 transcription without increasing extracellular 30 CXCL10 protein concentrations. We found that this transcriptionally independent 31 suppression of CXCL10 is mediated by the virulence factor and protease, glycoprotein-32 63 (gp63). Specifically, GP63 cleaves CXCL10 after amino acid A81 at the base of a C-33 terminal alpha-helix. Cytokine cleavage by GP63 demonstrated specificity, as GP63 34 cleaved CXCL10 and its homologues, which all bind the CXCR3 receptor, but not distantly 35 related chemokines, such as CXCL8 and CCL22. Further characterization demonstrated 36 that CXCL10 cleavage activity by GP63 was produced by both extracellular 37 promastigotes and intracellular amastigotes. Crucially, CXCL10 cleavage impaired T cell 38 chemotaxis in vitro, indicating that cleaved CXCL10 cannot signal through CXCR3. 39
Introduction 60
signaling axis coordinates an adaptive type-1 immune response to intracellular pathogens 116 that promotes a successful healing response. 117
Here, we report that L. major suppresses extracellular CXCL10 protein levels, 118 providing a potential mechanism for evasion of the adaptive immune response. This 119 suppression occurs through the proteolytic activity of the virulence factor glycoprotein-63 120 (GP63). GP63 cleavage of CXCL10 occurs throughout in vitro infection and abrogates 121 CXCR3-dependent T cell migration. Furthermore, we observed CXCL10 suppression with 122 other intracellular pathogens, including S. enterica and C. trachomatis, demonstrating that 123 diverse intracellular pathogens have developed convergent mechanisms to suppress 124
CXCL10. 125
As GP63 has a diverse set of identified in vitro substrates (48), we examined the 160 specificity of GP63 across a spectrum of chemokines. Based on the initial cytokine screen 161 ( Figure 1A) , we hypothesized GP63 cleavage would be restricted to CXCL10 and highly 162 related chemokines. To experimentally test for GP63 cleavage, purified recombinant 163 chemokines were incubated with conditioned media from L. major WT, L. major Δgp63, 164 or L. major Δgp63+1. GP63 cleavage was observed for CXCL9 (38.14% amino acid 165 identity with CXCL10) and CXCL11 (30.85% amino acid identity with CXCL10) (Figure  166 3A, B), which both signal through CXCR3. By contrast, no cleavage of CXCL8 (IL-8; a 167 neutrophil-attracting chemokine) or CCL22 (MDC; a Th2-attracting chemokine) was 168 detected (Fig. 3B ). Thus, chemokine cleavage by GP63 appears to preferentially degrade 169 chemokines involved in CXCR3 signaling. 170
Although western blot analysis supported GP63-dependent cleavage through loss 171 of CXCL10 immunoreactivity, it did not reveal the cleavage site or potential cleavage 172 products. The GP63 consensus cleavage site has been described as polar, hydrophobic, 173 and basic amino acids at positions P1, P1', and P2' (53) . Following this pattern, there are 174 three potential cleavage sites in the mature CXCL10 protein (from amino acid position 175 22-96) that are conserved between human and murine CXCL10 (68.37% amino acid 176 identity) (Fig. 3A) . In order to characterize the cleavage product(s), we incubated GP63 177 with human recombinant CXCL10 and visualized a shift in size by total protein stain ( Fig.  178   3C) . Intact CXCL10 and the largest cleavage products were determined to be 8.8kD and 179 6.6kD respectively, by capillary electrophoresis-mass spectrometry (CE-MS) ( Fig. 3D) . 180
After running the sample on a PAGE gel, the 8.8kD (intact, "Hi") product, 6.6kD (cleaved, 181 "Lo") product, and an uncleaved control ("Ctrl") were sequenced by trypsin digestion 182 followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Comparison 183 of peptides after trypsin digest revealed a peptide from amino acids (AA) 74-81 that was 184 exclusively present in the cleaved CXCL10 band, but notably absent in the uncleaved 185 band (Fig. 3E) . Conversely, distal peptide fragments such as AA84-91 were only present 186 in the uncleaved CXCL10. This analysis demonstrated cleavage occurring in between 187 A81 and I82, resulting in the loss of detectable peptides beyond those amino acids in 188 cleaved CXCL10. This is consistent with the fragment size based on intact molecular 189 weight CE-MS, and notably AIK (AA 81-83) is one of the three potential cleavage sites 190 identified in our comparative analysis (see Figure 3A ). To confirm this site as preferred 191
for GP63 cleavage, we used site-direct mutagenesis to mutate the residues in the 192 proposed cleavage motif. Mutation of the identified P1 residue significantly slowed 193 CXCL10 cleavage in a time course experiment (Fig. 3F ). Mapping the residues onto the 194 crystal structure of CXCL10 (54) demonstrated that cleavage occurs at the beginning of 195 the C-terminal alpha-helix of CXCL10 ( Fig. 3G ). 196 GP63 produced by L. major promastigotes or amastigotes can cleave CXCL10 197 protein. 198 Immediately after injection by the sand-fly vector, Leishmania parasites exist as an 199 extracellular, flagellated promastigote but are rapidly phagocytized where they transform 200 into the intracellular, aflagellated amastigote parasite stage. We hypothesized that GP63 201 would continue to be able to suppress CXCL10 through both stages of infection, as 202 transcriptomics indicate GP63 expression during both stages (50). To test the capacity of 203 L. major to suppress CXCL10 in both the promastigote and amastigote stage of infection, 204
we utilized PMA differentiated THP-1 monocytes as an intracellular macrophage model 205 of infection. Differentiated THP-1 monocytes were infected at an MOI of 20 with 206 promastigotes from L. major WT, gp63, or gp63+1. Extracellular promastigote activity 207 was assessed in the supernatant at 24 hours post infection, followed immediately by 208 washing to remove the extracellular promastigotes and GP63 protein in the media, and 209 subsequently assessing intracellular amastigote activity at 48 hours post infection. 210
This model demonstrated CXCL10 protein suppression by GP63 in both stages of 211 the parasite life cycle. L. major WT promastigotes had no induction of CXCL10 protein 212 relative to uninfected cells, while L. major gp63 infection resulted in a significant 213 induction of CXCL10 protein ( Fig. 4A) . Similarly, the L. major WT amastigotes continued 214 to suppress CXCL10 protein while L. major gp63 infection significantly induced CXCL10 215 protein (Fig. 4B ). The complementation observed with the L. major gp63+1 strain is 216 significant, though incomplete in the promastigote stage and further reduced in the 217 amastigote stage. This is attributable to the plasmid construct being designed for high 218 expression in the promastigote stage (55) and the lack of G418 selection during the 219 experiment. Notably, all three L. major strains cause comparable induction of CXCL10 220 mRNA ( Fig. 4C ). These results indicate that CXCL10 mRNA is induced during 221
Leishmania infection, but protein levels are reduced by GP63, present at both parasite 222 life cycle stages involved in infection in mammalian hosts. 223
GP63 cleaved CXCL10 is unable to recruit CXCR3 expressing T cells. 224
Because CXCL10 coordinates the recruitment of CXCR3+ T cells during infection, 225 we next tested if GP63 cleavage of CXCL10 impacts T cell recruitment. We tested the 226 chemotactic ability of cleaved CXCL10 to recruit Jurkat T cells expressing CXCR3. The 227 basal chamber of a transwell system was seeded with CXCL10 in the presence of 228 conditioned media from L. major WT, L. major gp63, or L. major gp63+1. Conditioned 229 media from L. major WT and L. major gp63+1 abrogated CXCL10 induced migration of 230 CXCR3+ Jurkat T cells, whereas the L. major gp63 conditioned media did not impair 231 chemotaxis ( Fig. 4D ). Together these data support a model whereby the host attempts to 232 produce CXCL10 to coordinate recruitment of CXCR3 expressing immune cells, but L. 233 major produces GP63 to inactivate CXCL10 and impair T cell chemotaxis ( Fig. 4E) . 234
CXCL10 suppression has evolved independently in multiple intracellular 235 pathogens 236
Given that CXCL10 mediates a type-1 immune response that protects against a 237 broad range of intracellular pathogens, we asked if suppression of CXCL10 has evolved 238 in has evolved in other parasites and bacteria. CXCL10 production by LCLs was 239 measured by ELISA after exposure to a variety of pathogens including Toxoplasma (T.) Confirmation and characterization of CXCL10 suppression in different cell lines 248 demonstrated that diverse intracellular pathogens impair chemokine accumulation. Using 249 a second LCL, we confirmed that S. Typhimurium and C. trachomatis infection suppress 250 CXCL10 ( Fig. 5B-C) . We then assessed the generalizability of CXCL10 suppression in 251 host cell types known to be commonly infected by each pathogen. THP-1 monocytes 252 stimulated with LPS upregulate significant production of CXCL10 protein, but infection 253 with live S. Typhimurium dramatically impaired this CXCL10 induction ( Fig. 5D ). Similarly, 254 the cervical epithelial cell line A2EN produces CXCL10 at baseline, but this is significantly 255 reduced after infection with C. trachomatis (Fig. 5E ). Thus, multiple intracellular 256 pathogens that pose significant health burdens around the globe have independently 257 evolved the ability to suppress CXCL10 in the cell types relevant to their infective niche. 258 259 Discussion 260
We describe a mechanism used by intracellular pathogens to evade host 261 chemokine response. Specifically, L. major can significantly reduce CXCL10 and impair 262 its chemotactic activity through the matrix-metalloprotease, GP63. This strategy is likely 263 to be highly beneficial to the parasite as CXCL10 protects against L. major (29), L. 264 amazonensis (26), and L. donovani infection (27, 28) . A similar phenotype of immune 265 evasion that is shared by diverse intracellular pathogens points to a critical conserved 266 role for CXCL10 in immunity to intracellular pathogens. 267
Consistent with CXCL10 playing a protective role during infection, multiple studies 268
show that recruitment of CXCR3-expressing cells actively shapes the immune response. 269
In response to Leishmania spp. specifically, CXCL10 is critical for the recruitment and 270 activation of several cell types that contribute to the coordination of a protective type-1 271 immune response: natural killer (NK) cells, CD8+ T cells, dendritic cells, and CD4+ Th1 272 cells. With the early upregulation of CXCL10 transcript (22), NK cells recruited during 273 infection produce IFN that contributes to Th1 differentiation (29, 56) . Specific subsets of 274 effector CD8+ T cells are recruited by CXCL10 after infection (23, 57). Finally, dendritic 275 cells exposed to CXCL10 produce increased IL12, a cytokine that promotes Th1 276 polarization, and Th1 cells exposed to CXCL10 produce greater amounts of IFN (58), a 277 signal which infected macrophages require for efficient parasite killing (6). Beyond 278 Leishmania, CXCR3-expressing cells have also been reported to play important roles in 279 other infectious and inflammatory models (19, 23, (59) (60) (61) (62) . After infection with lymphocytic 280 choriomeningitis virus, CXCR3 deletion leads to impaired production and localization of 281 effector CD8+ T cells (63), and CXCL10 precisely coordinates effector CD8+ T cells to 282 the site of Toxoplasma gondii, another intracellular eukaryotic pathogen (64). In response 283 to the bacterial pathogen S. Typhimurium, which we identified as also suppressing 284 CXCL10, mice have a significant expansion of CXCR3+ Th1 cells which border bacteria-285 rich granulomas in the spleen (43). These diverse examples highlight the importance of 286 evading the CXCL10-CXCR3 signaling axis for pathogens. 287
Current limitations of parasite genetics as they relate to the complexity of GP63 288 related proteases may contribute to an incomplete picture of the impact of GP63 on 289 chemokine suppression. First, sequencing L. major revealed proteins distantly 290 homologous to GP63 (approximately 35% amino acid identity) on chromosomes 24 and 291 31, in addition to the tandem array of gp63 genes on chromosome 10 (47, 65). These 292 related proteases may suppress CXCL10 during different stages of infection or cleave an 293 additional set of host substrates, even though they are not required for CXCL10 cleavage 294 under our in vitro conditions. Second, L. major gp63+1 has one of the seven 295 chromosome-10 gp63 copies maintained on a plasmid under G418 selection and 296 optimized for expression in promastigotes (55), making the currently available GP63 297 strains sub-optimal for in vivo experiments. Despite these limitations, we demonstrate that 298 GP63 cleavage of CXCL10 is selective, rapid, and renders the chemokine non-functional. 299
Further investigation beyond the scope of this manuscript will be required to elucidate the 300 implications of CXCL10 cleavage in other infection contexts and animal models. 301
An effective vaccine to protect against leishmaniasis has been a tantalizing 302 strategy for disease control with unrealized potential due to an incomplete understanding 303 of how the parasites interact with the immune system. Historically, inoculation with live 304 parasites in unexposed areas of skin has effectively prevented future infections (66); 305 however, this strategy poses significant risks (67-69) and subsequent vaccine 306 development efforts failed to confer long-term protection in human studies (66) The relevance of these insights into immune evasion is made more impactful by 321 the observation that CXCL10 suppression has arisen in multiple intracellular pathogens. 322
We found that L. major, S. Typhimurium, and C. trachomatis independently evolved the 323 ability to suppress CXCL10, which indicates that suppression of CXCR3 inflammatory 324 signaling is advantageous for multiple intracellular pathogens. In addition to S. 325 Gambian ancestry isolated in Gambia) were purchased from the Coriell Institute. LCLs 345 were maintained at 37˚C in a 5% CO2 atmosphere and were grown in RPMI 1640 media 346 (Invitrogen) supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine, 100 U/ml 347 penicillin-G, and 100 mg/ml 790 streptomycin. THP-1 monocytes, originally from ATCC, 348
were obtained from the Duke Cell Culture Facility and maintained in RPMI 1640 as 349 8mL of a 5-day-old culture was spun at 1200g for 10 min and washed with 5mL of HBSS 369 prior to counting promastigotes with a hemocytometer and resuspending at the indicated 370 concentration. As relevant controls in using these L. major strains, we found the strains 371 contained similar levels of metacyclic parasites based on flow cytometric measurement 372 (87) and metacyclic enrichment with peanut agglutinin (Fig. S1 ). 373
For Leishmania major infections of LCLs and THP-1 monocytes, 1x10 5 cells were 374 placed in 100l of RPMI 1640 assay media as described above, with no 375 penicillin/streptomycin added. In the case of THP-1 monocytes, cells were then stimulated 376 with 1g/mL of LPS derived from Salmonella enterica serovar Typhimurium S-form` (Enzo 377
Bioscience, ALX-581-011-L001). Finally, 1x10 6 L. major promastigotes were added in 378 50L of RPMI 1640 assay media for a multiplicity of infection (MOI) of 10. Culture 379 supernatants and cell pellets were collected after 24 hours of infection. For phorbol 12-380 myristate 13-acetate (PMA) differentiation of THP-1 monocytes, 1.2x10 6 cells were 381 placed in 2mL of complete RPMI 1640 media supplemented with 100ng/mL of PMA for 8 382 hours after which the RPMI media was replaced and cells allowed to rest for 36 hours. 383
Parasites were then washed and counted as described above and added at an MOI of 384 20. At 24 hours post-infection, the culture supernatant was removed, spun at 1200g for 385 10 minutes to separate extracellular parasites, and stored at -20C for downstream 386 cytokine analysis. Cells were then washed 3 times with 1mL of PBS followed by one 387 additional wash with 2mL of RPMI media to remove the remaining extracellular and Prugniaud A7) were performed as described previously (88). For Staphylococcus 395 aureus, LCLs were plated at 40,000 cells per 100l RPMI assay media in 96-well plates 396 prior to inoculation at an MOI of 10 with S. aureus Sanger-476. Cells were spun at 200xg 397 for 5 minutes prior to incubation at 37C for 1 hour. Gentamicin was added at 50µg/ml 398 and then supernatant was collected at 24 hours. For Cryptococcus neoformans, LCLs 399 were plated at 40,000 cells per 100l RPMI assay media in 96-well plates prior to 400 inoculation at an MOI of 5 with C. neoformans H99 strain. Cells were incubated at 37C 401 for 24 hours prior to collection of supernatant. For Plasmodium berghei infections, LCLs 402 were plated at 40,000 cells per 100l RPMI assay media in 96-well plates prior to 403 inoculation with 17,000 P. berghei-Luciferase sporozoites isolated from Anopheles 404 stephensi from the New York University Insectary Core Facility. Cells were spun at 405 1000xg for 10 minutes prior to incubation at 37ºC for 48 hours. Cell death was monitored 406 by 7AAD staining and quantified using a Guava easyCyte HT flow cytometer. To harvest 407 supernatants, LCLs were centrifuged at 200xg for 5 minutes prior to removing 408 supernatant and storing at -80ºC prior to quantifying chemokines production by ELISA. 409
For Mycobacterium marinum and Mycobacterium smegmatis infections, LCLs were 410 plated at 40,000 cells per 100l RPMI assay media without FBS and supplemented with 411 0.03% bovine serum albumin (BSA) prior to infection with 400,000 bacteria per well. Cells were spun at 100xg for 5 minutes prior to incubation at 33ºC for 3 hours, after which 50µl 413 of streptomycin in RPMI media was added for a final concentration of 200g/ml 414 streptomycin with 10% FBS, and incubation was continued at 33ºC for 24 hours. Cell 415 death was monitored by 7AAD staining and quantified using a Guava easyCyte HT flow 416 cytometer. To harvest supernatants, LCLs were centrifuged at 200xg for 5 minutes prior 417 to removing supernatant and storing at -80ºC prior to quantifying chemokines by ELISA. In vitro T cell migration 439 RPMI 1640 media (Sigma) was supplemented with 2% FBS and CXCL10 at a starting 440 concentration of 100nM. This was pre-incubated at a ratio of 1:1 with conditioned media 441 from either L. major WT, gp63, or gp63+1. After 12 hours of pre-incubation, 600µl of 442 CXCL10/conditioned media mix was added to a 24 well plate. 500,000 Jurkat T cells 443 stably transfected with CXCR3 were seeded onto the apical membrane of the 5m 444 transwell insert (Corning, 3421) , and allowed to incubate at 37C for 4 hours. The 445 transwell insert was removed and the concentration of cells in the basal chamber 446 determined using a Guava easyCyte HT flow cytometer (Millipore). 447 448
Expression of recombinant GP63 and site directed mutagenesis 449
Expression of CXCL10 and GP63 were performed by transfection in HEK293T 450 cells. HEK293Ts were maintained in complete DMEM media supplemented with 10% 451 FBS. Two days prior to transfection, 250,000 cells were washed and plated in a 6-well 452 tissue culture treated plate in 2mL of serum free, FreeStyle 293 Expression Media 453 (ThermoFisher, 12338018). One hour prior to transfection, media was replaced with fresh 454 FreeStyle media. Transfection was performed with 2.5 total g of endotoxin free plasmid 455 DNA using the Lipofectamine 3000 Transfection Reagent Kit per manufacturer's 456 instructions. Transfected HEK293Ts were incubated at 37C for 48 hours prior to harvesting culture supernatant and storing in polypropylene, low-binding tubes (Corning, 458 29442-578) at -80C until use. 459
The CXCL10 plasmid was obtained from Origene (NM_001565), and contains C-460
terminal Myc and Flag epitope tags. For GP63, a codon optimized plasmid was obtained 461 from OriGene on the pcDNA3.1/Hygro plasmid backbone. Following a kozak sequence 462 and secrecon to enhance secretion (89-91), GP63-1 based on the L. major Fd sequence 463 (Q4QHH2-1) was inserted with the Leishmania specific secretion signal and GPI anchor 464 motif removed (V100-N577) (92), and epitope tagged with Myc and His sequences placed 465 at the C-terminus. Point mutations in CXCL10 and GP63 were made using the Agilent 466
QuikChange Site Directed Mutagenesis kit according to manufacturer's instructions. 467
468
Mass spectrometry 469 CXCL10 exposed to GP63 for 5 hours, along with a negative (untreated) control 470 was delivered in PAGE loading buffer at an approximate concentration of 30 ng/uL. Mass 471 spectrometry was carried out by the Duke Proteomics and Metabolomics Shared 472
Resource. Molecular weight analysis of intact and cleaved CXCL10 from gel loading 473 buffer was performed using a ZipChip CE system (908 Devices, Inc) coupled to a Q 474
Exactive HF Orbitrap mass spectrometer (Thermo Scientific). Ammonium acetate was 475 added to the sample to a final concentration 0.1 M, and 5µL of the loading buffer was 476 pipetted manually into a HR ZipChip. Capillary electrophoresis (CE) separation was 477 performed at 500 V/cm with a 30 second injection in Metabolite BGE (908 Devices, Inc). as a spectral library, Skyline v4.1 was used to extract peak intensities for peptides which 496 looked to be a part of the cleavage region (residues 74-91) or non-cleaved region 497 (residues 48-68), in order to more definitively localize the specific cleavage location 498 ( Figure 2E ). Intensity was expressed as the peak area normalized to the protein region 499 from residues 29-52, in order to control for protein abundance differences between the 500 samples. The Skyline file has been made publicly available at Panoramaweb.org 501 (https://goo.gl/4xsLsF). Opportunity Program (SROP). JSS and SR were supported by NIH GM122798 and the 520 Burroughs Wellcome Fund Career Award for Medical Scientists. RLR was supported by 521 NIH AI119004. We thank Robyn Guo for assistance with immunoblotting, Sarah Rains for 522 assistance with sample prep for CXCL10 cleavage site identification, and Jeffrey S. 523
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the Duke University School of Medicine for the use of the Proteomics and Metabolomics 525 Shared Resource. 526 587 (Booth et al., 2002) , the A81, I82, K83 (P1, P1', P2') GP63 cleavage motif maps to an exposed 588 alpha-helical region. 
